Adverse Effects and Safety of Etirinotecan Pegol, a Novel Topoisomerase Inhibitor, in Cancer Treatment: A Systematic Review

Samare-Najaf, M; Samareh, A; Jamali, N; Abbasi, A; Clark, CCT; Khorchani, MJ; Zal, F

Zal, F (corresponding author), Shiraz Univ Med Sci, Sch Med, Dept Biochem, Shiraz, Iran.; Zal, F (corresponding author), Shiraz Univ Med Sci, Infertil Res Ctr, Shiraz, Iran.

CURRENT CANCER THERAPY REVIEWS, 2021; 17 (3): 234

Abstract

Background: Due to the increasing prevalence of cancer and the inadequacy of current therapies, the development of novel antitumor pharmaceutics with ......

Full Text Link